Antitumor activity of cis-diamminedichloroplatinum (II) against human tumor xenografts depends on its area under the curve in nude mice

Journal of Surgical Oncology

Volumn 61, Issue 2, 1996, Pages 138-142

  Kurihara, Naoto ^a   Kubota, Tetsuro ^a   Hoshiya, Yasunori ^a   Otani, Yoshihide ^a   Watanabe, Masahiko ^a   Kumai, Koichiro ^a   Kitajima, Masaki ^a  

^a KEIO UNIVERSITY   (Japan)

Author keywords

cisplatin; DDP; human gastric cancer xenograft; low dose consecutive infusion therapy; pharmacodynamic study

Indexed keywords

CISPLATIN; ANTINEOPLASTIC AGENT;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTINEOPLASTIC ACTIVITY; ARTICLE; BREAST CARCINOMA; CONTROLLED STUDY; DOSE RESPONSE; DRUG BLOOD LEVEL; HUMAN; HUMAN CELL; HUMAN TISSUE; INTRAPERITONEAL DRUG ADMINISTRATION; MOUSE; NONHUMAN; PRIORITY JOURNAL; STOMACH CARCINOMA; TUMOR XENOGRAFT; WEIGHT REDUCTION; ANIMAL; BAGG ALBINO MOUSE; CANCER TRANSPLANTATION; CELL CULTURE; DRUG ADMINISTRATION; EXPERIMENTAL NEOPLASM; INFUSION; MALE; NUDE MOUSE;

ANIMALS; ANTINEOPLASTIC AGENTS; CISPLATIN; DRUG ADMINISTRATION SCHEDULE; HUMANS; INFUSIONS, PARENTERAL; MALE; MICE; MICE, INBRED BALB C; MICE, NUDE; NEOPLASM TRANSPLANTATION; NEOPLASMS, EXPERIMENTAL; TUMOR CELLS, CULTURED;

EID: 0029664696     PISSN: 00224790     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1096-9098(199602)61:2<138::AID-JSO9>3.0.CO;2-D     Document Type: Article

References (19)

1. Gastrointestinal Tumor Study Group: Phase II-III chemotherapy studies in advanced gastric cancer. Cancer Treat Rep 63:1871-1876, 1979.
2. Leichman L, McDonald B, Dindogru A, et al.: An active drug in the treatment of disseminated gastric cancer. Cancer 53:18-22, 1984.
3. Beer M, Cocconi G, Ceci G, et al.: A phase II study of cisplatin in advanced gastric cancer. Eur J Cancer Clin Oncol 19:717-720, 1983.
4. Loehrer PJ, Einhorm LH: Cisplatin. Ann Intern Med. 100:704-713, 1984.
5. Chen JT, Hirai Y, Nakayama K. et al.: CDDP-ACR treatment for patients with recurrent ovarian cancer with prior chemotherapy containing CDDP. Acta Obst Gynecol Jpn 41:1565-1570, 1989.
6. Forastiere AA, Belliveau JF, Goren MP, et al.: Pharmacokinetic and toxicity evaluation of five-day continuous infusion versus intermittent bolus cis-diamminedichloroplatinum(II) in head and neck cancer. Cancer Res 48:3869-3874, 1988.
7. Jacobs C, Bertino J, Goffinet D, et al.: 24-hour infusion of cisplatin in head and neck cancer. Cancer (Phila) 42:2135-2140, 1987.
8. Giovanella BC, Stehlin JS, Williams LJ: Heterotransplantation of human malignant tumors in "nude" thymusless mice. II. Malignant tumors induced by injection of cell cultures derived from human solid tumors. J Natl Cancer Inst 52:921-930, 1974.
9. LeRoy AF, Wehling ML, Sponseller HL, et al.: Analysis of platinum in biological materials by flameless atomic absorption spectrophotometry. Biochem Med 18:184-191, 1977.
10. Kubota T, Inoue S, Furukawa T, et al.: Similarity of serum - tumor pharmacokinetics of antitumor agents in man and nude mice. Anticancer Res 13:1481-1484, 1993.
11. Shimoyama Y, Kubota T, Inoue S, et al.: Antitumor activity of cisplatin and carboplatin against human tumor xenografts serially transplanted into nude mice. Jpn J Cancer Chemother 14:2682-2687, 1987 (in Japanese, English Abstract).
12. Watanabe S, Tsugane S, Ohno Y: Prediction of the gastric cancer mortality in 2000 in Japan. Jpn J Cancer Res 79:439-444, 1988.
13. Kano T, Kumashiro R, Matsuda H, et al.: Recurrent gastric carcinoma-analysis of 100 in-patients. Jpn J Surg 13:106-111, 1983.
14. Miyamoto K, Yoshida S, Saito D, et al.: Pilot phase II study of cis-diamminedichloroplatinum (H) against metastatic gastric cancers. Jpn J Clin Oncol 20:169-176, 1990.
15. Derwinko B, Gottlieb JA: Action of Cis-dichlorodiammineplatinum (II) (NSC-119875) at the cellular level. Cancer Chemother Rep 59:665-673, 1975.
16. Taicahashi K, Ebihara K, Honda Y, et al.: Antitumor activity of cis-dichlorodiammineplatinum (II) and its effect on cell cycle progression. Jpn J Cancer Chemother 9 (4):624-631, 1982 (in Japanese, English Abstract).
17. Shimoyama M.: Implication of cell-kill-kinetics of anticancer agents in the design of optimal therapeutic schedules. Jpn J Cancer Chemother 3:1103-1110, 1976 (in Japanese, English Abstract).
18. Forestiere AA, Takasugi BJ, Baker SR, et al.: High dose cisplatin in advanced head and neck cancer. Cancer Chemother Pharmacol 19:155-158, 1987.
19. Chary KK: A phase II study of high dose cis- diamminedichloroplatinum II with forced diuresis. J Clin Hematol Oncol 7:633-644, 1977.